BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 17457049)

  • 1. p53: guardian of the genome and policeman of the oncogenes.
    Efeyan A; Serrano M
    Cell Cycle; 2007 May; 6(9):1006-10. PubMed ID: 17457049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ATR-Chk2 signaling in p53 activation and DNA damage response during cisplatin-induced apoptosis.
    Pabla N; Huang S; Mi QS; Daniel R; Dong Z
    J Biol Chem; 2008 Mar; 283(10):6572-83. PubMed ID: 18162465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p14ARF activates a Tip60-dependent and p53-independent ATM/ATR/CHK pathway in response to genotoxic stress.
    Eymin B; Claverie P; Salon C; Leduc C; Col E; Brambilla E; Khochbin S; Gazzeri S
    Mol Cell Biol; 2006 Jun; 26(11):4339-50. PubMed ID: 16705183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncogenes and the DNA damage response: Myc and E2F1 engage the ATM signaling pathway to activate p53 and induce apoptosis.
    Hong S; Pusapati RV; Powers JT; Johnson DG
    Cell Cycle; 2006 Apr; 5(8):801-3. PubMed ID: 16582589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ARF and ATM/ATR cooperate in p53-mediated apoptosis upon oncogenic stress.
    Pauklin S; Kristjuhan A; Maimets T; Jaks V
    Biochem Biophys Res Commun; 2005 Aug; 334(2):386-94. PubMed ID: 16004968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chk1 is dispensable for G2 arrest in response to sustained DNA damage when the ATM/p53/p21 pathway is functional.
    Lossaint G; Besnard E; Fisher D; Piette J; Dulić V
    Oncogene; 2011 Oct; 30(41):4261-74. PubMed ID: 21532626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ATM-Chk2-p53 activation prevents tumorigenesis at an expense of organ homeostasis upon Brca1 deficiency.
    Cao L; Kim S; Xiao C; Wang RH; Coumoul X; Wang X; Li WM; Xu XL; De Soto JA; Takai H; Mai S; Elledge SJ; Motoyama N; Deng CX
    EMBO J; 2006 May; 25(10):2167-77. PubMed ID: 16675955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional interaction of H2AX, NBS1, and p53 in ATM-dependent DNA damage responses and tumor suppression.
    Kang J; Ferguson D; Song H; Bassing C; Eckersdorff M; Alt FW; Xu Y
    Mol Cell Biol; 2005 Jan; 25(2):661-70. PubMed ID: 15632067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. STAT-1 facilitates the ATM activated checkpoint pathway following DNA damage.
    Townsend PA; Cragg MS; Davidson SM; McCormick J; Barry S; Lawrence KM; Knight RA; Hubank M; Chen PL; Latchman DS; Stephanou A
    J Cell Sci; 2005 Apr; 118(Pt 8):1629-39. PubMed ID: 15784679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of the ATM/ATR-mediated DNA damage response by the oncogenic phosphatase PPM1D.
    Lu X; Nguyen TA; Donehower LA
    Cell Cycle; 2005 Aug; 4(8):1060-4. PubMed ID: 15970689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphorylation of p53 serine 18 upregulates apoptosis to suppress Myc-induced tumorigenesis.
    Sluss HK; Gannon H; Coles AH; Shen Q; Eischen CM; Jones SN
    Mol Cancer Res; 2010 Feb; 8(2):216-22. PubMed ID: 20145032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The DNA damage signaling pathway is a critical mediator of oncogene-induced senescence.
    Mallette FA; Gaumont-Leclerc MF; Ferbeyre G
    Genes Dev; 2007 Jan; 21(1):43-8. PubMed ID: 17210786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor suppression by p53 in the absence of Atm.
    Bailey SL; Gurley KE; Hoon-Kim K; Kelly-Spratt KS; Kemp CJ
    Mol Cancer Res; 2008 Jul; 6(7):1185-92. PubMed ID: 18583527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of p53 renders ATM-deficient mice refractory to hepatocarcinogenesis.
    Teoh N; Pyakurel P; Dan YY; Swisshelm K; Hou J; Mitchell C; Fausto N; Gu Y; Farrell G
    Gastroenterology; 2010 Mar; 138(3):1155-65.e1-2. PubMed ID: 19919837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphorylation of Hdmx mediates its Hdm2- and ATM-dependent degradation in response to DNA damage.
    Pereg Y; Shkedy D; de Graaf P; Meulmeester E; Edelson-Averbukh M; Salek M; Biton S; Teunisse AF; Lehmann WD; Jochemsen AG; Shiloh Y
    Proc Natl Acad Sci U S A; 2005 Apr; 102(14):5056-61. PubMed ID: 15788536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ataxia-telangiectasia mutated is not required for p53 induction and apoptosis in irradiated epithelial tissues.
    Gurley KE; Kemp CJ
    Mol Cancer Res; 2007 Dec; 5(12):1312-8. PubMed ID: 18171989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ATM-dependent phosphorylation of heterogeneous nuclear ribonucleoprotein K promotes p53 transcriptional activation in response to DNA damage.
    Moumen A; Magill C; Dry KL; Jackson SP
    Cell Cycle; 2013 Feb; 12(4):698-704. PubMed ID: 23343766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Explaining oscillations and variability in the p53-Mdm2 system.
    Proctor CJ; Gray DA
    BMC Syst Biol; 2008 Aug; 2():75. PubMed ID: 18706112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromosomal breaks during mitotic catastrophe trigger γH2AX-ATM-p53-mediated apoptosis.
    Imreh G; Norberg HV; Imreh S; Zhivotovsky B
    J Cell Sci; 2011 Sep; 124(Pt 17):2951-63. PubMed ID: 21878502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 gain-of-function cancer mutants induce genetic instability by inactivating ATM.
    Song H; Hollstein M; Xu Y
    Nat Cell Biol; 2007 May; 9(5):573-80. PubMed ID: 17417627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.